Four new highly oxygenated 11-membered lactones (11-14) were synthesized by a combination of metabolic engineering techniques with complex chemical substrate synthesis.
Introduction
Botrytis cinerea is a grey powdery phytopathogenic mould that affects a large number of commercial crops. 1 Its major phytotoxic metabolites are a family of sesquiterpenes with the botryane carbon skeleton 2 and two groups of polyketides exemplified on the one hand, by the botcinic and botcineric acids (1) and their cyclic derivatives, the botcinins (2) 3 and on the other hand, by botrylactone (3). 4 A related lactone, 3,4-dihydroxy-2,4,6,8-tetramethyldec-8-enolide (4) has been isolated 5 from a mutant strain of B. cinerea. This lactone possesses the same carbon chain as botrylactone with identical functional groups and stereochemistry in the C1-C4 fragment as both the botcinins and botrylactone. This structural homology and the presence of compound 4 in cultures of the strains of B. cinerea which also produce large amounts of the botcinins, suggests that they have a common biosynthetic origin. Compound 4 may be a 'shunt' metabolite in this pathway. The sequencing of the B. cinerea genome led to the development of genetically modified strains lacking the genes which code for the enzymes that are involved in the biosynthesis of the secondary metabolites produced by this fungus. 6 Studies of the metabolites produced by these mutants permitted the identification of the genes involved in the production of the polyketides. 7 The genes responsible for the formation of the per-methylated tetraketide core of both botcinins (2) and botrylactones (3) are all included in the same cluster comprising genes BcBOA1 to BcBOA6. The latter encodes the polyketide synthase (PKS). 6 Naturally-occurring medium-sized lactones (8 to 11-membered lactones) constitute a relatively small number of metabolites which have nevertheless attracted considerable attention because of the range of biological activities which they possess. 8 In particular there are only a few examples of 11-membered lactones that are found in nature. 9 Apart from compound 4 and some complex pyrrolizidine and daphniphyllum alkaloids, there are only reports of two insect pheromones, ferrulactone I 10 and suspensolide, 11 and four fungal metabolites incluiding the aspercyclides A-C. 12 The latter have anti-inflammatory activity and have the potential to be used in the treatment of allergic disorders such as asthma. The relative thermodynamic instability of 11-membered lactones has made their synthesis and that of their derivatives difficult even using Mitsunobu lactonization 13 or an intramolecular Reformatsky reaction.
14 Recently ring-closing metathesis (RCM) has been developed to provide an efficient method for the preparation of some 11-membered lactones from acyclic precursors. 15 However RCM reactions in the macrocyclic series tend to give mixtures of the (E) and (Z) isomers of cyclic olefins. A reliable general method for controlling the geometry of the new double bond has yet to be found. 16 Consequently there are few examples of synthetic analogues whose biological activity has been thoroughly evaluated. Although botrylactone was described by Welmar et al. 17 as a powerful antibiotic whilst the botcinins have been reported 18 to show antifungal activity against Magnaporthe grisea, the causal agent of rice blast, nothing is known of the biological activity of compound 4 or its close relatives because of the small amount of material that has been isolated. Mutasynthesis is a very interesting strategy that combines chemical synthesis with biosynthetically-patterned biotrasformations using genetically engineered microorganisms. 19 The availability of mutants of B. cinerea blocked in the early stages of the pathway but retaining some of the later stages leading to these 11-membered lactones, has allowed us to explore the use of mutasynthesis to generate modified 11-membered lactones that are analogues of compound 4 in order to evaluate their biological activity.
Results and Discussion
We chose compound 5 as a simplified analogue of compound 4 although the stereochemistry of the alcohol at C-3 is different. However it could be easily synthesized in sufficient quantity for the mutasynthesis experiments. The retrosynthetic analysis of the lactone is shown in scheme 1. An RCM cyclization of the ester 6 and a syn aldol reaction of the aldehyde 7 play key roles in the stereoselective construction of the 11-membered lactone ring.
Scheme 1. Retrosynthetic analysis of lactone 5.
The synthetic sequence leading to the lactone 5 is shown in scheme 2. 2-Methyl-2-vinyloxirane was treated with commercially available 2-methylallyl magnesium chloride in the presence of CuI to produce the allylic alcohol 8 in a yield of 95%. 20 Oxidation of 8 with TEMPO-BAIB (2,2,6,6-tetramethyl piperidinyloxy-bis(acetoxy)iodobenzene) 21 afforded the aldehyde 7. This was then treated with the boron Z-enolate of the N-propionyl oxazolidinone (-)-(R)-9 22 to give the syn-aldol product 10 in 70% yield and 88% d.e.
† Exocyclic cleavage of the oxazolidinone 10 with allyl alcohol and 4 eq. of allylmagnesium bromide at -20ºC generated the ester 6 with a yield of 67%. Finally an RCM reaction of 6 under high dilution conditions catalysed by the second generation ruthenium complex A 23 in dry, degassed, refluxing dichloromethane produced the 11-membered lactone 5 with a good regioselectivity and yield (9:1 E/Z ratio, 68% yield).
¥, † This is in agreement with molecular mechanics calculations (MM2) which predict that the (E)-alkene is the most stable regioisomer. 24 Scheme 2. Stereoselective synthesis of 5.
The lactone 5 was then incubated with two mutant strains of B. cinerea, bcbot2∆ and bcboa6∆bcbot2∆ (bc∆∆d1). The first mutant which was obtained by deactivating the botryane biosynthesis gene BcBOT2 that encodes a sesquiterpene cyclase, 25 does not produce the botryanes but does produce a significant amount of botcinic acid (1a) and its relatives. The second mutant, bc∆∆d1, 6 is a double mutant which was obtained by deactivating the genes BcBOT2 and BcBOA6 and is consequently unable to produce the three characteristic families of metabolite: the botryanes, the botcinins and botrylactone. 6 Incubation of compound 5 with both mutant strains using liquid surface-culture conditions gave four new 11-membered lactones 11-14 (figure 2). Their distribution and % yields are shown in table 1. Strain bcbot2∆ gave a higher conversion of compound 5. The metabolites 11, 12 and 13 were produced in both cases but there was no apparent incorporation of compound 5 into the botcinin/botrylactone pathway. The structures of the metabolites were established from their 1 H and 13 C NMR spectra using a combination of 1D and 2D NMR experiments (see ESI). Compound 11 was obtained as a colourless oil whose HRMS possessed a molecular ion at m/z 240.1353 corresponding to the molecular formula, C 13 H 20 O 4 . The 13 C NMR spectrum contained resonances at δ C 81.6, 62.9, 59.8 and 58.6 ppm (CH, CH 2 , C, and CH carbons respectively) and at δ C 174.4 ppm (C carbon) consistent with the presence of four C-O and one lactone C=O carbon atoms in the molecule. The main difference between the 1 H NMR spectra of compounds 5 and 11 was the absence of the olefinic proton H-9 and the appearance of a double-doublet (J 10.0 and 4.2 Hz) at δ H 3.01 ppm in compound 11. The presence of an epoxide at this position was confirmed by an HSQC correlation of H-9 with the signal at δ C 58.6 ppm (C-9) and HMBC correlations between H-9 and signals at δ C 59.8 (C-8) and δ C 62.9 ppm (C-10). The stereochemistry of the oxirane ring was established by nOe experiments which were rationalized on the basis of the lowest energy optimized conformer derived from MM2 calculations (figure 3). 24 In particular there were interactions between H-9 and δ H 5.17 (H-5), δ H 2.16-2.08 (H-6β), and δ H 1.08 (H-7β) and between the signals at δ H 1.75 (4-Me) and δ H 1.31 (8-Me). There were also nOe effects involving the signals at δ H 3.99 (H-3β) and δ H 1.28 (2-Meβ). These were consistent with the epoxidation of compound 5 on the β-face of the ring. 26 Based on the known absolute configuration of compound 5 and the MM2 calculations, compound 11 has the absolute configuration (2R,3R,4E,8S,9S). The HRMS (m/z 239.1282, M-H + ) of compound 12 was consistent with a molecular formula, C 13 H 20 O 4 . The 13 C NMR spectrum contained 13 signals. Comparison with compound 5 showed that the resonance for C-7 [δ C 38.2 (t)] had changed to δ C 77.2 (d) in compound 12. There were COSY correlations between δ H 4.18 (H-7) and the signals at δ H 2.46 and 2.30 which were assigned to H-6α and H-6β respectively. There were nOe effects which were observed (figure 3) between the signals at δ H 4.18 (H-7), 5.62 (H-9), 5.02 (H-5) and H-6β, together with δ H 4.70 (H-10β) and H-9. These were consistent with the R configuration at C-7 and hence compound 12 was (2R,3R,4E,7R,8E)-3,7-dihydroxy-2,4,8-trimethyldeca-4,8-dienolide. The HRMS data for compounds 13 and 14 showed that they both had a molecular formula, C 13 H 20 O 5 . Their 13 C NMR spectra contained five C-O signals at δ C 81.4 (CH, C-3), 76.9 (CH, C-7), 62.6 (C, C-8) 62.2 (CH 2 , C-10) and 56.6 (CH, C-9) ppm for compound 13 and δ C 80.9 (CH, C-3), 65.9 (CH, C-6), 62.8 (CH 2 , C-10) 58.6 (CH, C-9) and 58.0 (C, C-8) ppm for 14. H-5) . The nOe effects, shown in figure 3, were in accord with the optimized structures obtained by MM2 calculations 24 and, bearing in mind the origin of the metabolites, led to the absolute stereochemistry for compounds 13 and 14 as 2R,3R,4E,7R,8S,9S and 2R,3R,4E,6R,8S,9S respectively. These mutasynthetic transformations have produced derivatives that were hydroxylated at C-6 and C-7 and regioselectively epoxidized at C-8/C9. However there was no hydration of epoxidation of the C4/C5 double bond. Consequently additional synthetic work is necessary in order to develop an efficient route for the synthesis of closer analogues of compound 4. Compounds 11 and 13 did not show any significant antibacterial activity at a concentration of 200 ppm against Escherichia coli, Bacillus subtilus or Streptococcus faecalis. 27 Compounds 11 and 13 did not show any significant phytotoxic activitiy when tested in vivo on sterilized leaves of Phaseolus vulgaris at a concentration of 500 ppm.
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Conclusions
The regioselective ring-closing metathesis of the triene 6 has provided an efficient method for the asymmetric synthesis of (2R,3R,4E,8E)-3-hydroxy-2,4,8-trimethyldeca-4,8-dienolide (E)-5 in 5 steps with 26% overall yield from simple starting materials. This compound is an advanced analogue of 3,4-dihydroxy-2,4,6,8-tetramethyldec-8-enolide (4) which is a scarce metabolite of B. cinerea. Compound 5 was biotransformed by two mutant strains of B. cinerea, bcbot2∆ and bc∆∆d1 into four new highly oxygenated 11-membered lactones. These mutasynthetic steps involved regioselective epoxidation of the C8/C9 double bond and hydroxylation at either the C-6 (minor) or C-7 (major) positions. This has proved to be a valuable and versatile approach to increasing the structural diversity of 11-membered lactones. Further experiments are in progress to develop a synthesis of compound 4.
Experimental
General procedures
Unless otherwise noted, materials and reagents were obtained from commercial suppliers and were used without further purification. Dichloromethane was freshly distilled from CaH 2 and tetrahydrofuran was dried over sodium and benzophenone and freshly distilled before use. 25, δ C 77.0). NMR assignments were made using a combination of 1D and 2D techniques. Multiplicities are described using the following abbreviations: s=singlet, d=doublet, t=triplet, q=quarter; quint=quintuplet; sext=sextuplet; m=multiplet, br=broad. High-Resolution Mass Spectroscopy (HRMS) was recorded with a double-focusing magnetic sector mass spectrometer in positive ion mode or with a QTOF mass spectrometer in positive ion electrospray mode at 20 V cone voltage. HRESIMS/MS experiments were performed with a QTOF mass spectrometer at 20 V cone voltage and 10 eV collision energy.
Microorganisms
B. cinerea mutants, bcbot2∆ and bc∆∆d1, were previously obtained by deactivating the genes encoding the sesquiterpene synthase BcBOT2, 25 and the synthase BcBOT2 and the polyketide synthase BcBOA6, 6 respectively, and are maintained in the BIOGER strain collection INRA (Grignon, France). Conidial stock suspensions of these strains were maintained in glycerol (80%) at -40ºC.
Synthesis of the substrates (E)-2,6-dimethylhepta-2,6-dien-1-ol (8).
2-Methylallylmagnesium chloride (58.4 mL of a 0.5 M solution in THF, 29.2 mmol) at -30ºC was added to a stirred solution of 2-methyl-2-vinyloxirane (2 mL, 20.9 mmol) and CuI (199 mg, 1.04 mmol) in dry THF (22 mL) at -30ºC. The mixture was stirred at -30ºC and after 3h was treated with a saturated ammonium chloride solution (60 mL) and then allowed to warm to room temperature. The aqueous layer was extracted three times with diethyl ether (90 mL). Combined extracts were washed with HCl 1N (200 mL), saturated sodium bicarbonate (200 mL), water (200 mL), brine (200 mL) and then dried over anhydrous sodium sulphate. Finally, the solvent was concentrated under reduced pressure and the crude was purified by silica gel column chromatography eluted with pentane : Et 2 O (80:20) to yield compound 8 (2756 mg, 94 %) as a colourless oil. Spectroscopic data of compound 8 were identical to those described in the literature.
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(E)-2,6-dimethylhepta-2,6-dienal (7) . TEMPO (890 mg, 5.6 mmol) and (diacetoxyiodo) benzene (BAIB, 18.3 g, 83.7 mmol) were added at 0 ºC to a solution of (E)-2,6-dimethylhepta-2,6-dien-1-ol (8) (3.9 g, 27.9 mmol) in dry CH 2 . After complete addition, the mixture was stirred at 0ºC for 15 min. The yellow solution was re-cooled to -78ºC and a solution of (E)-2,6-dimethylhepta-2,6-dienal (7) (1220 mg, 8.71 mmol) was added dropwise in dry CH 2 Cl 2 (2.0 mL). The mixture was stirred at -78ºC and was then allowed to warm to 0ºC and stirred for an additional hour. The reaction was quenched with a mixture of phosphate buffer (5 mL of a 1.0 M solution at pH 7) and MeOH (15 mL) at 0ºC and the mixture was stirred for 5 min. Finally, a solution 2.4:1 MeOH:H 2 O 2 30% (15 mL) was added slowly at 0ºC and was stirred for an additional hour. The solvent was concentrated under reduced pressure and the residue was re-dissolved in diethyl ether. The aqueous layer was extracted three times with diethyl ether (35 mL). Combined extracts were washed with brine (200 mL), dried over anhydrous sodium sulphate, filtered, the solvent evaporated and the crude was purified by silica gel column chromatography eluted with petroleum ether: ethyl acetate . Allylmagnesium bromide (4.9 mL of a 1.0 M solution in Et 2 O, 4.9 mmol) was added at 0ºC to alcohol (15 mL) under argon conditions in a Schlenk flask. The allylic mixture was stirred for 10 min and re-cooled at -20ºC. Then, a solution of 10 (886 mg, 2.40 mmol) in allylic alcohol (3 mL) was slowly added. When TLC monitoring indicated the completion of the reaction (3h), a saturated ammonium chloride solution (20 mL) was added and then allowed to warm to room temperature. The aqueous layer was extracted three times with diethyl ether (50 mL). Combined extracts were washed with brine (100 mL), dried over anhydrous sodium sulphate, filtered and the solvent was concentrated under reduced pressure. 
RCM of 6.
(1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)tricyclohexylphosphine)ruthenium (Grubbs ruthenium catalyst A, 121.3 mg, 0.14 mmol) was added to a refluxed and stirred solution of ester 6 (180.0 mg, 0.71 mmol) in degassed and dry CH 2 Cl 2 (420 mL) under argon conditions. The reaction mixture was stirred until consumption of the starting material (20 h). The crude was filtered over a pad of silica gel and washed with ethyl acetate (400 mL). The solvent was removed under reduced pressure to give a crude that was purified by silica gel column chromatography eluted with ether petroleum: ethyl acetate (90:10). Final purification was carried out by semi-preparative HPLC (ether petroleum: ethyl acetate 85:15; flow = 3.0 mL/min) to yield a mixture 9:1 of (E)-5 (108.6 mg, 68%) and (Z)-5. 6 fresh conidia or six uniform discs of 0.9 cm diameter mycelial of four-day old culture on malta agar. A filter-sterilised aqueous solution of the labeled precursor or a solution of (E)-5 in ethanol was fed at a carefully determined optimum time. Roux bottles were incubated at 25±2ºC in daylight under static conditions for the optimum period of time. The culture medium and mycelia were then separated by filtration. The broth was separated with NaCl and extracted with ethyl acetate (3X) and dried over anhydrous Na 2 SO 4 . The organic extract obtained was evaporated at reduced pressure to dryness.
Feeding of (2R,3R,4E,8E)-3-hydroxy-2,4,8-trimethyldeca 
